Contact: Mika Ono
Scripps Research Institute
Caption: Researchers at the Scripps Research Institute and Vanderbilt University have achieved an important new understanding of the mGlu1 receptor, a target for future medicines for the treatment of brain disorders.
Credit: Image by Katya Kadyshevskaya, courtesy of the Scripps Research Institute
Usage Restrictions: None
Related news release: Scientists create detailed picture of protein linked to learning, pain and brain disorders